Skip to content

13F-HR filed by Propel Bio Management, LLC

Propel Bio Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 17:36:40 UTC, with 30 holding rows worth $188,617,909.

Accession
0001829126-26-012373
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 30 entries on the cover page, a total value of $188,617,909 stated on the cover page (in dollars after the unit check, H1), rows summing to $188,617,909 with VALUE read as dollars as filed, 13F file number 028-23914. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PLAINS GP HLDGS L P72651A207LTD PARTNR INT A1,272,360$32,954,124dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK3,864,148$31,260,957dollars as filed
DELCATH SYSTEMS INC24661P807COMMON STOCK604,664$9,656,484dollars as filed
COLLEGIUM PHARMACEUTICAL INC19459J104COM410,175$8,950,019dollars as filed
CORCEPT THERAPEUTICS INC218352102COM75,274$8,673,823dollars as filed
AQUESTIVE THERAPEUTICS INC COM03843E104Stock278,723$8,608,753dollars as filed
Milestone Pharmaceuticals Inc59935V107COM9,449,727$8,180,629dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK1,105,913$8,073,165dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS549,186$6,831,874dollars as filed
ORCHESTRA BIOMED HOLDINGS IN68572M106COMMON STOCK896,701$5,577,480dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock191,998$5,218,506dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW956,007$5,019,037dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM696,436$4,958,624dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK700,595$4,764,046dollars as filed
INVENTIVA SA46124U107ADS1,133,954$4,184,290dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK2,049,471$3,934,984dollars as filed
SAB BIOTHERAPEUTICS INC78397T202COMMON STOCK1,187,422$3,764,128dollars as filed
PROKIDNEY CORP74291D104CMN2,009,733$3,336,157dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM264,310$3,044,851dollars as filed
PALISADE BIO INC696389402COMMON STOCK2,224,189$3,002,655dollars as filed
OCULAR THERAPEUTIX INC67576A100COM357,966$2,745,599dollars as filed
SCYNEXIS INC811292309COM541,474$2,674,882dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock179,154$2,563,694dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK1,018,721$2,536,615dollars as filed
IMMUNIC INC4525EP200COM NEW236,734$2,201,626dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK335,389$1,767,500dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK270,036$1,306,974dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW37,539$1,216,639dollars as filed
SPYGLASS PHARMA INC85220G109COMMON STOCK41,418$1,076,868dollars as filed
LeonaBio Inc04746L203COM149,279$532,926dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001829126-26-012373this filing2026-11-13